Red Nucleus Acquires Bridge Medical Consulting

February 5, 2026

Red Nucleus has acquired Bridge Medical Consulting, a UK-based health economics and outcomes research (HEOR) consultancy, to broaden its HEOR, real-world evidence, and market access capabilities for biopharmaceutical clients. The firm will be merged into Red Nucleus's existing HEOR business to expand evidence synthesis, economic modeling, RWE research, and AI-enabled workflows.

Buyers
Red Nucleus
Targets
Bridge Medical Consulting
Platforms
Red Nucleus
Location
United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.